Endo Continue Scheduled Insulin Modify Nutritional Severity Basal Dose Reduction

---
name: endo-continue-scheduled-insulin-modify-nutritional-severity-basal-dose-reduction
description: The clinician continues the patient's pre‑admission scheduled insulin regimen, adjusting it for current nutritional status and illness severity to keep glucose between 100–180 mg/dL. Trigger phrases include a basal insulin dose ≥0.6 units/kg/day, altered nutritional intake, or worsening illness severity.
---

# Continue scheduled insulin regimen adjusted for nutritional status and illness severity; consider basal dose reduction for heavy regimens

## STEP 1 — Gather Information
Collect pre‑admission insulin regimen (type, total daily dose, basal proportion), current weight, nutritional intake (NPO, PO, tube feeds), illness severity (e.g., infection, glucocorticoids, surgery), recent glucose values, and renal function; calculate basal dose in units/kg/day and decide whether dose reduction may be warranted.

## STEP 2 — Rule In / Rule Out
Is the basal insulin dose ≥0.6 units/kg/day? If yes, proceed to consider dose reduction; if no, continue the current basal dose without reduction and proceed to glucose monitoring.

## STEP 3 — Classify or Stratify
Classify nutritional status as NPO/minimal intake, reduced PO intake, or regular diet/tube feeds; and illness severity as stable vs worsening (e.g., new infection, high‑dose steroids). Decide on basal reduction magnitude: 10% for mild/moderate changes, up to 20% for severe catabolism or markedly decreased intake.

## STEP 4 — Decide
Reduce basal insulin by the selected percentage (10‑20%); keep prandial and correctional insulin doses unchanged unless nutritional intake changes; order glucose checks every 4–6 hours (more often if labile) and adjust correctional insulin as needed to maintain glucose 100‑180 mg/dL.

## Clinical Guardrails / Mimics / Pitfalls
Do not reduce basal insulin in type 1 diabetes or patients prone to DKA; avoid discontinuing basal entirely; do not rely on sliding‑scale insulin alone when basal dose is high; monitor for hypoglycemia if oral intake suddenly improves; do not apply reduction if the patient is receiving substantial carbohydrate‑containing enteral nutrition.

## Concrete Clinical Example
An 80‑kg patient admitted for myocardial infarction takes glargine 60 units nightly (basal 0.75 units/kg/day) and insulin aspart with meals. Initially NPO, then advances to 50% of usual PO intake. Basal dose ≥0.6 units/kg/day, illness severe, intake reduced → reduce basal by 20% to 48 units nightly; resume prandial aspart as diet advances; check glucose q4h and give correctional aspart as needed to keep glucose 100‑180 mg/dL.

**Source:** Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2022, https://doi.org/10.1210/clinem/dgac278

> **TODO:** consider adding scripts/calc.py for the endo-continue-scheduled-insulin-modify-nutritional-severity-basal-dose-reduction calculator